村田 聡一郎

Articles:  1-1 of 1

  • The Eltrombopag antitumor effect on hepatocellular carcinoma

    Kurokawa Tomohiro , Murata Soichiro , Zheng Yun-Wen , Iwasaki Kenichi , Kohno Keisuke , Fukunaga Kiyoshi , Ohkohchi Nobuhiro , 村田 聡一郎 , 高野 恵輔 , 福永 潔 , 大河内 信弘

    Currently, sorafenib is the only available chemotherapeutic agent for advanced hepatocellular carcinoma (HCC), but it cannot be used in patients with liver cirrhosis (LC) or thrombocytopenia. In these …

    International journal of oncology 47(5), 1696-1702, 2015-11

    IR 

Page Top